THE MONOTHERAPEUTIC ROLE OF GEOMIN FORTE IN THE POST-INFARCTION PERIOD

Abstract

The aim of our work was to study the mono therapeutic role of the mineral Geomin - Forte in the post-myocardial infarction period. In the Office of Preventive Cardiology of the International Society of the Commonwealth of Foreign Countries of Georgia, in 2018-2022, we conducted outpatient observation of the monotherapeutic capabilities of Geomin Forte on 68 (10 women, 58 men) patients. As a result of the conducted investigations, it was determined: 1. Geomin Forte is harmless and its use does not cause both side effects and individual incompatibilities in patients with heart attack. 2. Geomin Forte significantly increases the body's energy resources, which is so necessary for patients with heart attacks. 3. Geomin Forte creates prospects for its wide use in the future in both treatment and prevention of ischemic heart disease.